Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pelargonium sidoides extract is an herbal drug preparation derived from the roots of the Pelargonium sidoides plant, which is native to South Africa. [16] It is widely used for treating acute respiratory tract infections, including acute bronchitis, sinusitis, the common cold, and tonsillitis. [3, 4] The primary standardized extract is known as EPs 7630, which is manufactured by Dr. Willmar Schwabe Pharmaceuticals. [24] The mechanism of action is multifactorial, involving immunomodulatory, antiviral, and antibacterial properties. [6, 7] It has been shown to modulate the immune system by inducing cytokines like interferon-β and TNF-alpha, stimulating natural killer cell activity, and increasing phagocytosis. [2, 21] Its antiviral effects include inhibiting viral replication and preventing viruses from attaching to host cells. [5, 8] Additionally, it exhibits antibacterial effects by preventing bacteria from adhering to host cells and possesses mucolytic properties by increasing ciliary beat frequency, which helps clear mucus from the respiratory tract. [2, 5, 16] The extract is available in various forms, including oral solutions (drops) and tablets. [3, 11]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pelargonium sidoides extract.